Drug Type Trispecific T-cell engager (TriTE) |
Synonyms |
Target |
Action stimulants, antagonists, inhibitors |
Mechanism CD3 stimulants(T cell surface glycoprotein CD3 stimulants), CEACAM5 antagonists(Carcinoembryonic antigen related cell adhesion molecule 5 antagonists), CEACAM6 inhibitors(Carcinoembryonic antigen related cell adhesion molecule 6 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization ![]() |
Active Organization- |
Inactive Organization ![]() |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | China | ![]() | - |